Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19?

<p>Cochrane is producing a series of reviews to help decision makers respond to the COVID-19 pandemic. In September 2021, we published the first version of a Living Systematic Review on the effects of monoclonal antibodies for treating COVID-19 and in this podcast we speak to Nina Kreuzberger one of the lead authors, about the review, which was initiated in the Germany-wide joint projects "COVIM" and "CEOsys" and funded by the Federal Ministry of Education and Research of Germany.</p><img src="http://feeds.feedburner.com/~r/PodcastsFromTheCochraneLibrary/~4/E9CCkiIC8xs" height="1" width="1" alt=""/>